Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Alembic Pharmaceuticals Limited ( (IN:APLLTD) ) has shared an update.
Alembic Pharmaceuticals Limited has announced a change in the email address for its Registrar and Share Transfer Agent, MUFG Intime India Private Limited. This update, effective from October 1, 2025, introduces a new generic email ID for investors, which will be used across all companies serviced by MIIPL, potentially streamlining communication and improving investor relations.
More about Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the development, manufacture, and marketing of pharmaceutical products. The company is known for its wide range of generic and specialty drugs, catering to various therapeutic segments.
Average Trading Volume: 7,649
Technical Sentiment Signal: Sell
Current Market Cap: 174.9B INR
For detailed information about APLLTD stock, go to TipRanks’ Stock Analysis page.